Chronic lymphocytic leukemia (CLL) is considered a clonal B cell malignancy. Sporadically, CLL cases with multiple productive heavy and light‐chain rearrangements were detected, thus leading to a bi‐ or oligoclonal CLL disease with leukemic cells originating either from different B cells or otherwise descending from secondary immunoglobulin rearrangement events. This suggests a potential role of clonal hematopoiesis or germline predisposition in these cases. During the screening of 75 CLL cases for kappa and lambda light‐chain rearrangements, we could detect a single case with CLL cells expressing two distinct kappa and lambda light chains paired with two separate immunoglobulin heavy‐chain variable regions. Furthermore, this patient also developed a prostate carcinoma. Targeted genome sequencing of highly purified light‐chain specific CLL clones from this patient and from the prostate carcinoma revealed the presence of a rare germline polymorphism in the POLE gene. Hence, our data suggest that the detected SNP may predispose for cancer, particularly for CLL.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Steiner, M., Gassner, F. J., Parigger, T., Neureiter, D., Egle, A., Geisberger, R., … Zaborsky, N. (2021). A POLE splice site deletion detected in a patient with biclonal CLL and prostate cancer: A case report. International Journal of Molecular Sciences, 22(17). https://doi.org/10.3390/ijms22179410